Free Trial
NYSE:BIO.B

Bio-Rad Laboratories (BIO.B) Stock Price, News & Analysis

Bio-Rad Laboratories logo
$247.05 0.00 (0.00%)
As of 08/22/2025

About Bio-Rad Laboratories Stock (NYSE:BIO.B)

Key Stats

Today's Range
$247.05
$247.05
50-Day Range
$247.05
$289.13
52-Week Range
$225.29
$359.22
Volume
62 shs
Average Volume
36 shs
Market Capitalization
$6.72 billion
P/E Ratio
21.06
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIO.B Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BIO.B Stock News Headlines

Fed Decision Warning: How to Protect Your Wealth Before September 17th
On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the fallout. Whether Powell hikes or cuts, both paths lead to wealth destruction for unprepared investors. American Alternative Assets just released the Mar-A-Lago Accord, revealing how elites are positioning ahead of the decision—and how you can do the same.tc pixel
Bio-Rad Labs B (BIOb) Earnings Dates & Reports
Bio-Rad price target lowered to $409 from $430 at RBC Capital
See More Headlines

BIO.B Stock Analysis - Frequently Asked Questions

Bio-Rad Laboratories' stock was trading at $325.60 at the beginning of the year. Since then, BIO.B shares have decreased by 24.1% and is now trading at $247.05.

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) posted its earnings results on Thursday, July, 31st. The company reported $2.61 earnings per share for the quarter. Bio-Rad Laboratories had a trailing twelve-month return on equity of 4.01% and a net margin of 12.50%.

Bio-Rad Laboratories subsidiaries include these companies: Celsee, Raindance Technologies Limited, GnuBIO Inc., Bio-Rad AbD Serotec GmbH, QuantaLife, DiaMed Holding AG, Blackhawk Biosystems, and more.

Shares of BIO.B stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/31/2025
Today
8/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:BIO.B
CIK
12208
Employees
8,200
Year Founded
1952

Profitability

EPS (Trailing Twelve Months)
$11.73
Trailing P/E Ratio
21.06
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.84 billion
Net Margins
12.50%
Pretax Margin
17.62%
Return on Equity
4.01%
Return on Assets
2.82%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
5.12
Quick Ratio
3.67

Sales & Book Value

Annual Sales
$2.57 billion
Price / Sales
2.62
Cash Flow
$10.39 per share
Price / Cash Flow
23.77
Book Value
$234.52 per share
Price / Book
1.05

Miscellaneous

Outstanding Shares
27,210,000
Free Float
19,490,000
Market Cap
$6.72 billion
Optionable
Not Optionable
Beta
0.76

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:BIO.B) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners